Table 1. Baseline characteristics.
Paclitaxel group (n=46) | Fluorouracil group (n=47) | |
---|---|---|
Age, years | 65 (48–82; 60–73) | 67 (44–83; 61–74) |
| ||
Sex | ||
Male | 38 (83%) | 40 (85%) |
Female | 8 (17%) | 7 (15%) |
| ||
Zubrod performance status | ||
0 | 42 (91%) | 42 (89%) |
1 | 4 (9%) | 5 (11%) |
| ||
Tumour stage | ||
T2 | 44 (96%) | 44 (94%) |
T3–4 | 2 (4%) | 3 (6%) |
Data are median (range; IQR) or n (%).